Collection
Metabolic
GLP-1 & metabolic research compounds
GLP-1, dual, and triple incretin agonists for metabolic-pathway research, including Semaglutide, Tirzepatide, Retatrutide, and Cagrilintide, alongside AOD-9604 and MOTS-c for adipose and mitochondrial research models. Every batch ships with a Certificate of Analysis confirming purity and identity via HPLC and mass spectrometry. Supplied strictly for laboratory research into energy homeostasis and metabolic signaling — not for human or animal use.
≥98%AOD-9604
hGH (176-191) fragment
$60.005 mg
≥98%Cagrilintide
Long-acting amylin analog
$112.0010 mg
≥98%MOTS-c
Mitochondrial-derived peptide
$55.0010 mg
≥98%Retatrutide
Triple GIP / GLP-1 / glucagon agonist
from $130.002 sizes
≥98%Semaglutide
GLP-1 receptor agonist
$110.0010 mg
≥98%Tesamorelin
Stabilized GHRH analog
$77.0010 mg
≥98%Tirzepatide
Dual GIP / GLP-1 receptor agonist
$190.0030 mg